Cobas ampliprep-requirement for a cost per test for testing of human immunodeficiency virus for base year plus one option year.

Ended Awarded Last action

Contract number
N0025919F0149
Awardee
Awarding agency
Obligated
$91,618

Award facts

Contract value 50% obligated
$183,235.04 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 · MOD to add gfebs funding FY21 $91,618
Exercise an Option P00001 · Cobas ampliprep MOD to exercise option quantity $0
Original award $91,618

About this award

Roche Diagnostics Corporation received a $183,235.04 firm fixed-price delivery order from the Bureau of Medicine and Surgery (BUMED), a component of the Department of Defense, for HIV testing services using the COBAS AmpliPrep system on a cost-per-test basis. The contract covers a base year plus one option year, with an ultimate completion date of April 1, 2021, and performance at Roche's facility in Castleton, Indiana. This delivery order was issued without a set-aside designation, reflecting open competition, and is a child contract under the Critical Analyzers, Laboratory General Services Administration Schedule (FSS-66-III).

The award aligns with Roche Diagnostics' established federal contracting presence as a primary supplier of advanced diagnostic capabilities to military and civilian healthcare systems. The company maintains multiple active indefinite delivery contracts and blanket purchase agreements with various Defense Health Agency installations and Veterans Integrated Service Networks, providing comprehensive molecular diagnostics, laboratory instruments, reagents, and testing services. This COBAS AmpliPrep delivery order supports BUMED's requirement for infectious disease testing capabilities within the military healthcare system.

Quick answers

Who was awarded contract N0025919F0149?

N0025919F0149 was awarded to Roche Diagnostics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on September 16, 2019.

How much is contract N0025919F0149 worth?

The government has obligated $91,618 on N0025919F0149. Its current value, with exercised options, is $183,235.

Is contract N0025919F0149 an order under another contract?

Yes. N0025919F0149 is a delivery order under V797D70105, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract N0025919F0149 competed?

The extent of competition for N0025919F0149 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award